HomeInsightsStock Comparison

Bacil Pharma Ltd vs Influx Healthtech Ltd Stock Comparison

Bacil Pharma Ltd vs Influx Healthtech Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Bacil Pharma Ltd is ₹ 35.8 as of 30 Jun 15:30.
  • The P/E Ratio of Bacil Pharma Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Bacil Pharma Ltd changed from ₹ 0.97 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Bacil Pharma Ltd for the Mar '25 is ₹ 0.09 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Bacil Pharma Ltd for the Mar '25 is ₹ 0.02 crore as compare to the Dec '24 ebitda of ₹ -0.06 crore. This represent the decline of -133% The ebitda of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Bacil Pharma Ltd changed from ₹ 0.02 crore to ₹ 0.02 crore over 8 quarters. This represents a CAGR of 0.00% The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Bacil Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bacil Pharma Ltd

  • Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90.
  • The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs.
  • Domestic operations are spread across pan India.
  • The company has strong field force of 500 plus, spread over various States and Districts.
  • It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage.

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

Bacil Pharma Ltd News Hub

News

Bacil Pharma to table results

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 26 May 2025. ...

Read more

19 May 2025 11:38

News

Bacil Pharma to discuss results

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 21 January 20...

Read more

14 Jan 2025 14:13

News

Bacil Pharma to convene EGM

Bacil Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be...

Read more

24 Oct 2024 21:01

News

Bacil Pharma to convene board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 23 October 20...

Read more

17 Oct 2024 12:34

News

Bacil Pharma schedules board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 15 October 20...

Read more

11 Oct 2024 10:31

News

Bacil Pharma announces board meeting date

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 27 September ...

Read more

23 Sep 2024 10:09

Influx Healthtech Ltd News Hub

News

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public of...

Read more

25 Jun 2025 11:42

SWOT Analysis Of Bacil Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bacil Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bacil Pharma Ltd and Influx Healthtech Ltd

Which company has a larger market capitalization, Bacil Pharma Ltd or Influx Healthtech Ltd?

Market cap of Bacil Pharma Ltd is 21 Cr while Market cap of Influx Healthtech Ltd is 304 Cr

What are the key factors driving the stock performance of Bacil Pharma Ltd and Influx Healthtech Ltd?

The stock performance of Bacil Pharma Ltd and Influx Healthtech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bacil Pharma Ltd and Influx Healthtech Ltd?

As of July 5, 2025, the Bacil Pharma Ltd stock price is INR ₹35.8. On the other hand, Influx Healthtech Ltd stock price is INR ₹131.35.

How do dividend payouts of Bacil Pharma Ltd and Influx Healthtech Ltd compare?

To compare the dividend payouts of Bacil Pharma Ltd and Influx Healthtech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions